Stockhead on MSN
Health Check: Aft Pharmaceuticals’ revenue and drug development ambitions are running to plan
With extensive upcoming drug launches, NZ's Aft Pharmaceuticals is confident of hitting its $270 million revenue target by March 2027.
AutoZone stands out as a structural growth story, with commercial driving double-digit gains. Read more to see why AZO stock ...
Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” second quarter 2025 investor letter. A copy ...
Practical Classics on MSN
Austin/MG/Rover Montego
Richard Gelder’s 1.6 HL is one of many Montegos he has owned.
Omai Gold Mines Corp. (TSXV: OMG) (OTCQB: OMGGF) ("Omai Gold" or the "Company") is pleased to announce additional assay results from the ongoing 2025 drill program on its 100% owned Omai Gold Project ...
The Nature Conservancy has announced that it will purchase and oversee four hydroelectric dams on the lower Kennebec River in Maine, paving the way for their eventual removal. The sale ...
Nokia and Boldyn Networks have deployed a private 5G network at Callio FutureMINE in Pyhäjärvi, Finland, converting one of Europe’s deepest m ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback